论文信息 - Amyloid-Beta (1-40) Peptide and Subclinical Cardiovascular Disease. - 字舞流文

Amyloid-Beta (1-40) Peptide and Subclinical Cardiovascular Disease.

A. Khera | C. Ayers | J. D. de Lemos | E. Brilakis | K. Stamatelopoulos | K. Drosatos | K. Stellos | A. Gatsiou | G. Georgiopoulos | C. Pol | Konstantinos Drosatos

[1] A. Zeiher,et al. Amyloid- (1-40) and Mortality in Patients With NonST-Segment Elevation Acute Coronary Syndrome , 2018, Annals of Internal Medicine.

[2] M. Domingo,et al. Amiloide beta (1-40) en sangre, cognición y pronóstico en insuficiencia cardiaca , 2017 .

[3] C. Ayers,et al. Sedentary Behavior and Subclinical Cardiac Injury: Results From the Dallas Heart Study. , 2017, Circulation.

[4] M. Frosch,et al. Aβ Amyloid Pathology Affects the Hearts of Patients With Alzheimer's Disease: Mind the Heart. , 2016, Journal of the American College of Cardiology.

[5] Christoph Laske,et al. Amyloid-beta (1-40) and the risk of death from cardiovascular causes in patients with coronary heart disease. , 2015, Journal of the American College of Cardiology.